Yu-Dong Xiao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Radiofrequency Ablation

Computed Tomography

Machine Learning

Liver Metastases

Top Venues

Alimentary pharmacology & therapeutics

Abdominal radiology (New York)

Journal of hepatocellular carcinoma

Insights into imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Zhou, Yan Bao, De-Hua Chang, Jun-Xiang Li, Tian-Zhi An, Ya-Ping Shen, Wen-Wu Cai, Lu Wen, Yu-Dong Xiao
Identification of proliferative hepatocellular carcinoma using the SMARS score and implications for microwave ablation. Insights into imaging 15 (1) (2024)
Hui-Zhou Li, Qing-Qing Liu, De-Hua Chang, Shu-Xian Li, Long-Tao Yang, Peng Zhou, Jiang-Bei Deng, Chang-Hao Huang, Yu-Dong Xiao
Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy. Biomedicines 11 (8) (2023)
Yao Tong, De-Hua Chang, Yu-Dong Xiao
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' reply. Alimentary pharmacology & therapeutics 57 (7) (2023)
Hong-Mei Li, Wei Huang, Chao Hu, Zi-Shu Zhang, Yu-Dong Xiao, Tian-Cheng Wang
Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection. Journal of hepatocellular carcinoma 10 (2023)
Yan Bao, Jun-Xiang Li, Peng Zhou, Yao Tong, Li-Zhou Wang, De-Hua Chang, Wen-Wu Cai, Lu Wen, Jun Liu, Yu-Dong Xiao
Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization. Radiology 308 (2) (2023)
Yao Tong, Ran Cai, Jun-Xiang Li, De-Hua Chang, Li-Zhou Wang, Wen-Wu Cai, Yu-Dong Xiao
Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
De-Hua Chang, Yu-Dong Xiao, Tong Yao
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics 57 (1) (2022)
De-Hua Chang, Yu-Dong Xiao, Tong Yao
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics 57 (1) (2022)
De-Hua Chang, Yu-Dong Xiao, Tong Yao
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics 57 (1) (2022)
Jie Tan, René Michael Mathy, De-Hua Chang, Tian Tang, Zi-Shu Zhang, Yu-Dong Xiao
Combined transarterial iodized oil injection and computed tomography-guided thermal ablation for hepatocellular carcinoma: utility of the iodized oil retention pattern. Abdominal radiology (New York) (2021)
Zhi-Min Zou, De-Hua Chang, Hui Liu, Yu-Dong Xiao
Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? Insights into imaging 12 (1) (2021)
Hui-Zhou Li, Jie Tan, Tian Tang, Tian-Zhi An, Jun-Xiang Li, Yu-Dong Xiao
Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study. Journal of hepatocellular carcinoma 8 (2021)
Tian-Cheng Wang, Zi-Shu Zhang, Yu-Dong Xiao
Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma. Journal of pain research 13 (2020)
Pei-Yao Tao, Zi-Shu Zhang, Tian-Cheng Wang, Meng-Qi Yu, Yu-Dong Xiao
A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging. Abdominal radiology (New York) 46 (2) (2020)
Zi-Shu Zhang, Hui-Zhou Li, Cong Ma, Yu-Dong Xiao
Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety. BMC cancer 19 (1) (2019)